share_log

Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate

Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate

陽光生物製藥第一季度每股收益美元(2.00)未達到預期(1.04)美元,銷售額754萬美元超過700萬美元的預期
Benzinga ·  05/21 08:16

Sunshine Biopharma (NASDAQ:SBFM) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.04) by 92.31 percent. This is a 75 percent increase over losses of $(8.00) per share from the same period last year. The company reported quarterly sales of $7.54 million which beat the analyst consensus estimate of $7.00 million by 7.73 percent. This is a 54.08 percent increase over sales of $4.89 million the same period last year.

陽光生物製藥(納斯達克股票代碼:SBFM)公佈的季度虧損爲每股2.00美元,比分析師普遍預期的1.04美元(1.04美元)低92.31%。這比去年同期每股虧損8.00美元(8.00)增長了75%。該公司公佈的季度銷售額爲754萬美元,比分析師普遍預期的70萬美元高出7.73%。這比去年同期的489萬美元銷售額增長了54.08%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論